| 
																	
																	
																		 Connection
 
																		 Laura Dunn to Phenotype  
																		
																	 
																		This is a "connection" page, showing publications Laura Dunn has written about Phenotype.   
																		
																	 
																			
																					
	
						
				
		
			
			
			|  | 
				
					|  | Connection Strength |  |  
					|  |   |  |  
					|  | 0.241 |  |  |  |  
		
		
			
				Dunn LB, Aouizerat BE, Langford DJ, Cooper BA, Dhruva A, Cataldo JK, Baggott CR, Merriman JD, Dodd M, West C, Paul SM, Miaskowski C. Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers. Eur J Oncol Nurs. 2013 Jun; 17(3):346-53.	
				
				
					Score: 0.081
				
				Miaskowski C, Cooper BA, Aouizerat B, Melisko M, Chen LM, Dunn L, Hu X, Kober KM, Mastick J, Levine JD, Hammer M, Wright F, Harris J, Armes J, Furlong E, Fox P, Ream E, Maguire R, Kearney N. The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1?week following chemotherapy. Eur J Cancer Care (Engl). 2017 May; 26(3).	
				
				
					Score: 0.025
				
				Langford DJ, Paul SM, West CM, Dunn LB, Levine JD, Kober KM, Dodd MJ, Miaskowski C, Aouizerat BE. Variations in potassium channel genes are associated with distinct trajectories of persistent breast pain after breast cancer surgery. Pain. 2015 Mar; 156(3):371-380.	
				
				
					Score: 0.024
				
				Merriman JD, Aouizerat BE, Cataldo JK, Dunn LB, Kober K, Langford DJ, West C, Cooper BA, Paul SM, Miaskowski C. Associations between catecholaminergic, GABAergic, and serotonergic genes and self-reported attentional function in oncology patients and their family caregivers. Eur J Oncol Nurs. 2015 Jun; 19(3):251-9.	
				
				
					Score: 0.023
				
				Miaskowski C, Cataldo JK, Baggott CR, West C, Dunn LB, Dhruva A, Merriman JD, Langford DJ, Kober KM, Paul SM, Cooper BA, Aouizerat BE. Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers. Support Care Cancer. 2015 Apr; 23(4):953-65.	
				
				
					Score: 0.023
				
				Dhruva A, Aouizerat BE, Cooper B, Paul SM, Dodd M, West C, Wara W, Lee K, Dunn LB, Langford DJ, Merriman JD, Baggott C, Cataldo J, Ritchie C, Kober KM, Leutwyler H, Miaskowski C. Cytokine gene associations with self-report ratings of morning and evening fatigue in oncology patients and their family caregivers. Biol Res Nurs. 2015 Mar; 17(2):175-84.	
				
				
					Score: 0.022
				
				Merriman JD, Aouizerat BE, Cataldo JK, Dunn L, Cooper BA, West C, Paul SM, Baggott CR, Dhruva A, Kober K, Langford DJ, Leutwyler H, Ritchie CS, Abrams G, Dodd M, Elboim C, Hamolsky D, Melisko M, Miaskowski C. Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer. Cytokine. 2014 Feb; 65(2):192-201.	
				
				
					Score: 0.022
				
				Alfaro E, Dhruva A, Langford DJ, Koetters T, Merriman JD, West C, Dunn LB, Paul SM, Cooper B, Cataldo J, Hamolsky D, Elboim C, Kober K, Aouizerat BE, Miaskowski C. Associations between cytokine gene variations and self-reported sleep disturbance in women following breast cancer surgery. Eur J Oncol Nurs. 2014 Feb; 18(1):85-93.	
				
				
					Score: 0.021
				 | 
																	
																		
																			
																					              Connection Strength             
  The connection strength for concepts is the sum of the scores for each matching publication.
 Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
 |